Debiopharm Further Explores the Potential of its Potent, Highl...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LAUSANNE, Switzerland, December 16, 2021 /PRNewswire-AsiaNet/ - - Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumorsDebiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced...
Authors: LATEST ASIANET NEWS RELEASES